InsiderTrades

Form 4 for LLY Lilly (Eli)

Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0000059478-23-000061 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-14 2023-02-10 LLY Ricks David A Pres, COB, CEO, Dir A - Grant $345.12 +56.2K 443.8K +15% +$19.40M
D 2023-02-14 2023-02-08 LLY Ricks David A Pres, COB, CEO, Dir G - Gift $0.00 -4,200 387.5K -1% $0
D 2023-02-14 2023-02-10 LLY Ricks David A Pres, COB, CEO, Dir A - Grant $0.00 +29.6K 29.6K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-10 A A 56,208 $345.12 443,751 D — —
2 Common Common Stock 2023-02-08 G D 4,200 $0.00 387,543 D — — (F1) On February 8, 2023, the Reporting Person transferred 4,200 shares of Eli Lilly and Company common stock to a spousal lifetime access trust, of which the Reporting Person's wife is the trustee and the Reporting Person's wife and children are beneficiaries. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose.
3 Derivative Restricted Stock Unit 2023-02-10 A A 29,611 $0.00 29,611 D — · 2024-02-01 to 2024-02-01 29,611 Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.